Involvement of dopamine-dependent and -independent mechanisms in the rewarding effects mediated by δ opioid receptor subtypes in mice

Brain Research

Volumn 744, Issue 2, 1997, Pages 327-334

  Suzuki, Tsutomu ^a   Tsuji, Minoru ^a   Mori, Tomohisa ^a   Ikeda, Hiroko ^a   Misawa, Miwa ^a   Nagase, Hiroshi ^b  

^a HOSHI UNIVERSITY   (Japan)

^b TORAY INDUSTRIES INC   (Japan)

Author keywords

opioid receptor; conditioned place preference; dopamine turnover; mesolimbic dopamine system; reward

Indexed keywords

7 BENZYLIDENENALTREXONE; DELTA OPIATE RECEPTOR; DELTORPHIN; ENKEPHALIN DERIVATIVE; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; NALTRIBEN; OPIATE AGONIST; OPIATE ANTAGONIST; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONDITIONING; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REWARD; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESICS; ANIMALS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; MALE; MICE; RECEPTORS, OPIOID, DELTA; REWARD;

EID: 0031015658     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01119-5     Document Type: Article

References (36)

1. Amalric, M. and Koob, G.F., Low doses of methylnaloxonium in the nucleus accumbens antagonize hyperactivity induced by heroin in the rat, Pharmacol Biochem. Behav., 23 (1985) 411-415.
2. Bals-Kubik, R., Shippenberg, T.S. and Herz, A., Involvement of central μ. and δ opioid receptors in mediating the reinforcing effects of ß-endorphin in the rat, Eur. J. Pharmacol, 175 (1990) 63-69.
3. Bozarth, M.A. and Wise, R.A., Heroin reward is dependent on a dopaminergic substrate. Life Sci., 29 (1981) 1881-1886.
4. Bozarth, M.A., Neuroanatomical boundaries of the reward-relevant opiate-receptor field in the ventral tegmental area as mapped by the conditioned place preference method in rats., Brain Res., 414 (1987) 77-84.
5. Chang, J.K. and Cuatrecasas, P., Multiple opiate receptors: enkephalins and morphine bind to receptors of different specificity, J. Biol. Chem., 254 (1979) 2610-2618.
6. Di Chiara, G. and Imperato, A., Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats, J. Pharmacol. Exp. Ther., 244(1988) 1067-1080.
7. Ettenberg, A., Pettit, H.O., Bloom, F.E. and Koob, G.F., Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems, Psychopharmacology, 78 (1982) 204-209.
8. Funada, M., Suzuki, T., Narita, M., Misawa, M. and Nagase, H., Blockade of morphine reward through the activation of κ-opioid receptors in mice, Neuropharmacology, 32 (1993) 1315-1323.
9. Haley, T.J. and McCormick, W.G., Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse, Br. J. Pharmacol., 12 (1957) 12-15.
10. 6]enkephalin and naltrindole 5′-isothiocyanate: evidence for delta receptor subtypes, J. Pharmacol. Exp. Ther., 257 (1991) 1069-1075.
11. Kalivas, P.W., Widerlov, E., Stanley, D., Breese, G. and Prange, A.J., Jr., Enkephalin action on the mesolimbic system: A dopamine-dependent and a dopamine-independent increase in locomotor activity, J. Pharmacol. Exp. Ther., 227 (1983) 229-237.
12. Kalivas, P.W. and Bronson, M., Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin, Neuropharmacology, 24 (1985) 931-936.
13. Leon, P. and Di Chiara, G., Blockade of D-1 receptors by SCH 23390 antagonizes morphine-and amphetamine-induced place preference conditioning, Eur. J. Pharmacol., 135 (1987) 251-254.
14. 1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens, J. Neurosci., 11 (1991) 1565-1576.
15. Lord, J.A.H., Waterfield, A.A., Hughes, J. and Kosterlitz, H.W., Endogenous opioid peptides: multiple agonists and receptors, Nature, 267(1977) 495-499.
16. Manzanares, J., Durham, R.A., Lookingland, K.J. and Moore, K.E., δ-Opioid receptor-mediated regulation of central dopaminergic neurons in the rat, Eur. J. Pharmacol., 249 (1993) 107-112.
17. Matthews, W.R. and German, D.C., Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neuron by morphine, Neuroscience, 11 (1984) 617-625.
18. 2]deltorphin II in mice: Evidence for delta receptor subtypes, J. Pharmacol. Exp. Ther., 258 (1991) 583-587.
19. Mognan, J., Paterson, S.J., Tavani, A. and Kosterlitz, H.W., The bind spectrum of narcotic analgesic drugs with different agonist and antagonist properties, Naunyn-Schmiedeberg's Arch. Pharmacol., 319 (1982) 197-205.
20. Narita, M., Suzuki, T., Funada, M., Misawa, M. and Nagase, H., Involvement of δ-opioid receptors in the effects of morphine in locomotor activity and the mesolimbic dopaminergic system in mice, Psychopharmacology, 111 (1993) 423-426.
21. Pert, A. and Sivit, C., Neuroanatomical focus for morphine and enkephalin-induced hypermotility, Nature, 265 (1977) 645-647.
22. Pettit, H.O., Ettenberg, A., Bloom, F.E. and Koob, G.F., Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats, Psychopharmacology, 84 (1984) 167-173.
23. Phillips, A.G. and LePiane, F.G., Reinforcing effects of morphine microinjection into the ventral tegmental area, Pharmacol. Biochem. Behav., 12 (1980) 965-968.
24. 5-enkephalinamide into the ventral tegmental area, Behav. Brain. Res., 5 (1982) 225-229.
25. Shippenberg, T.S., Bals-Kubik, R. and Herz, A., Motivational properties of opioids: evidence that an activation of δ-receptors mediates reinforcement proccesses, Brain Res., 436 (1987) 234-239.
26. 1-dopamine receptors in the motivational properties of μ-and κ-opioid agonists, Brain Res., 436 (1987) 169-172.
27. Shippenberg, T.S. and Herz, A., Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists, Eur. J. Pharmacol., 151 (1988) 233-242.
28. Spanagel, R., Herz, A. and Shippenberg, T.S., The effects of opioid peptides on dopamine release in the nucleus accumbens: An in vivo microdialysis study, J. Neurochem., 55 (1990) 1734-1740.
29. Spyraki, C., Fibiger, N.C. and Phillips, A.G., Attenuation of heroin reward in rats by disruption of mesolimbic dopamine system, Psychopharmacology, 79 (1983) 278-283.
30. Stinus, L., Nadaud, D., Jauregui, J. and Kelley, A.E., Chronic treatment with five different neuroleptics elicits behavioral supersensitivity to opiate infusion into the nucleus accumbens, Biol. Psychiatry, 21 (1986) 34-48.
31. Stinus, L., Nadaud, D., Deminiere, J.M., Jauregui, J., Hand, T.T. and Le Moal, M., Chronic flupentixol treatment potentiates the reinforcing properties of systemic heroin administration, Biol. Psychiatry, 26 (1989) 363-371.
32. Suzuki, T., Masukawa, Y. and Misawa, M., Drug interactions in the reinforcing effects of over-the-counter cough syrups, Psychopharmacology, 102 (1990) 438-442.
33. Suzuki, T., Funada, M., Narita, M., Misawa, M. and Nagase, H., Pertussis toxin abolishes μ-and δ-opioid agonist-induced place preference, Eur. J. Pharmacol., 205 (1990) 85-88.
34. Suzuki, T., Funada, M., Narita, M., Misawa, M. and Nagase, H., Morphine-induced place preference in the CXBK mouse: characterisistics of μ opioid receptor subtypes, Brain Res., 602 (1993) 45-52.
35. Suzuki, T., Yoshiike, M., Mizoguchi, H., Kamei, J., Misawa, M. and Nagase, H., Blockade of δ-opioid receptors prevents morphine-induced place preference in mice, Jpn. J. Pharmacol., 66 (1994) 131-137.
36. 2 opioid receptor agonists in mice, Psychopharmacology, 124 (1996) 211-218.